Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 15 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Angiogenesis Inhibitors [Clear All Filters]
(2019).
(2017).
Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer..
Clin Breast Cancer. 14(5), 330-8.
(2014). ranibizumab in the management of advanced Coats disease Stages 3B and 4: long-term outcomes..
Retina. 34(11), 2275-81.
(2014). Is copper chelation an effective anti-angiogenic strategy for cancer treatment?.
Med Hypotheses. 81(6), 1159-63.
(2013). Role of bevacizumab in colorectal cancer growth and its adverse effects: a review..
World J Gastroenterol. 19(31), 5051-60.
(2013). Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel..
Anticancer Res. 32(10), 4569-80.
(2012). Reversible posterior leukoencephalopathy syndrome induced by pazopanib..
BMC Cancer. 12, 489.
(2012). Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization..
Acta Ophthalmol. 89(3), 218-21.
(2011). Low dose of bevacizumab is safe and effective in preventing bleeding episodes in hereditary hemorrhagic telangiectasia..
Am J Gastroenterol. 106(12), 2204-6.
(2011). Angiogenic growth factors and their inhibitors in diabetic retinopathy..
Curr Diabetes Rev. 6(5), 304-12.
(2010). Bevacizumab in the treatment of breast cancer..
Cancer Treat Rev. 36(1), 75-82.
(2010). The effect of bevacizumab on colon anastomotic healing in rats..
Int J Colorectal Dis. 25(12), 1465-73.
(2010). The effect of subconjunctival ranibizumab on primary pterygium: a pilot study..
Cornea. 29(12), 1373-9.
(2010). A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer..
Cancer Chemother Pharmacol. 65(4), 649-60.
(2010).